Contact +1 (919) 234-1277
  • Antibody-drug conjugates

    Antibody Drug Conjugates (ADCs) in Cancer Therapy

    Thomas Meyer Thomas Meyer 7 min read

    In the relentless battle against cancer, researchers continually seek innovative strategies to enhance treatment efficacy while minimizing adverse effects on healthy tissues. The development of novel therapies that…

  1. Peptide synthesis

    What are the challenges in chemical and recombinant peptide production processes and how to overcome them?

    Read more
  2. Antibody-drug conjugates

    Everything you need to know about the generation of antibody-drug conjugates (ADCs)

    Read more
  3. Peptide synthesis

    How to leverage peptide design strategies to increase your candidate’s stability and reactivity

    Read more
  4. Custom Antibody

    Revolutionizing Immunotherapy with Phage Display

    Read more
  5. Blog

    Humanized vs. Fully Human Antibodies: What’s the Difference?

    Read more

Let’s talk about science – Scientists in the spotlight

Dr. Louisa James

“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists” – Interview with Dr. Louisa James (QMUL)

Read more
Queen Mary University of London (QMUL, UK) Queen Mary University of London (QMUL, UK)
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists” – Interview with Dr. Louisa James (QMUL)
Dr. Mara Freire

Reinventing IgY biotherapeutics – interview with Dr. Mara Freire (CICECO, University of Aveiro, Portugal)

Read more
CICECO, University of Aveiro, Portugal CICECO, University of Aveiro, Portugal
Reinventing IgY biotherapeutics – interview with Dr. Mara Freire (CICECO, University of Aveiro, Portugal)
Dr. Melanie Conrad

How the environment shapes immune system development during pregnancy – interview with Dr. Melanie Conrad

Read more
Charité Medical University in Berlin, Germany Charité Medical University in Berlin, Germany
How the environment shapes immune system development during pregnancy – interview with Dr. Melanie Conrad
Dr. Mohamed Alfaleh

“Cell-based phage display is helping us isolate more biologically relevant antibodies” – Interview with Dr. Mohamed Alfaleh (King Abdulaziz University)

Read more
King Abdulaziz University King Abdulaziz University
“Cell-based phage display is helping us isolate more biologically relevant antibodies” – Interview with Dr. Mohamed Alfaleh (King Abdulaziz University)
Prof. Tomáš Kalina

“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation” – Interview with Prof. Tomáš Kalina (Charles University in Prague)

Read more
Charles University in Prague Charles University in Prague
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation” – Interview with Prof. Tomáš Kalina (Charles University in Prague)
Prof. Richard Pleass

“Antibodies will make a significant contribution to design effective control strategies for COVID-19” – Interview with Prof. Richard Pleass (LSTM)

Read more
LSTM LSTM
“Antibodies will make a significant contribution to design effective control strategies for COVID-19” – Interview with Prof. Richard Pleass (LSTM)
Professor Istvan Toth

“Simplicity is the key to successful large-scale applications” – Interview with Professor Istvan Toth (Queensland University, Australia)

Read more
Queensland University, Australia Queensland University, Australia
“Simplicity is the key to successful large-scale applications” – Interview with Professor Istvan Toth (Queensland University, Australia)
See More

Read by topic

Cart (0 Items)

Your cart is currently empty.

View Products